[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Gene-Deleted Vaccines Market Report 2016

September 2016 | 124 pages | ID: E0B48369A8BEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Gene-Deleted Vaccines

Revenue, means the sales value of Gene-Deleted Vaccines

This report studies sales (consumption) of Gene-Deleted Vaccines in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Bayer HealthCare AG (Germany)
  • Biogenesis-Bago (Argentina)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Sante Animale (France)
  • Heska Corporation (US)
  • Indian Immunologicals Ltd (India)
  • Lohmann Animal Health (US)
  • Merck Animal Health (US)
  • Merial Ltd. (US)
  • Protein Sciences Corporation (US)
  • Virbac SA (France)
  • Zoetis Inc. (US)
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Gene-Deleted Vaccines in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Gene-Deleted Vaccines in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Gene-Deleted Vaccines Market Report 2016

1 GENE-DELETED VACCINES OVERVIEW

1.1 Product Overview and Scope of Gene-Deleted Vaccines
1.2 Classification of Gene-Deleted Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Gene-Deleted Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Gene-Deleted Vaccines Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Gene-Deleted Vaccines (2011-2021)
  1.5.1 Europe Gene-Deleted Vaccines Sales and Growth Rate (2011-2021)
  1.5.2 Europe Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)

2 EUROPE GENE-DELETED VACCINES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Gene-Deleted Vaccines Market Competition by Manufacturers
  2.1.1 Europe Gene-Deleted Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Gene-Deleted Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Gene-Deleted Vaccines (Volume and Value) by Type
  2.2.1 Europe Gene-Deleted Vaccines Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Gene-Deleted Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Europe Gene-Deleted Vaccines (Volume and Value) by Countries
  2.3.1 Europe Gene-Deleted Vaccines Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Gene-Deleted Vaccines Revenue and Market Share by Countries (2011-2016)
2.4 Europe Gene-Deleted Vaccines (Volume) by Application

3 GERMANY GENE-DELETED VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Gene-Deleted Vaccines Sales and Value (2011-2016)
  3.1.1 Germany Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
  3.1.2 Germany Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Gene-Deleted Vaccines Sales Price Trend (2011-2016)
3.2 Germany Gene-Deleted Vaccines Sales and Market Share by Manufacturers
3.3 Germany Gene-Deleted Vaccines Sales and Market Share by Type
3.4 Germany Gene-Deleted Vaccines Sales and Market Share by Application

4 FRANCE GENE-DELETED VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 France Gene-Deleted Vaccines Sales and Value (2011-2016)
  4.1.1 France Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
  4.1.2 France Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
  4.1.4 France Gene-Deleted Vaccines Sales Price Trend (2011-2016)
4.2 France Gene-Deleted Vaccines Sales and Market Share by Manufacturers
4.3 France Gene-Deleted Vaccines Sales and Market Share by Type
4.4 France Gene-Deleted Vaccines Sales and Market Share by Application

5 UK GENE-DELETED VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 UK Gene-Deleted Vaccines Sales and Value (2011-2016)
  5.1.1 UK Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
  5.1.2 UK Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
  5.1.5 UK Gene-Deleted Vaccines Sales Price Trend (2011-2016)
5.2 UK Gene-Deleted Vaccines Sales and Market Share by Manufacturers
5.3 UK Gene-Deleted Vaccines Sales and Market Share by Type
5.4 UK Gene-Deleted Vaccines Sales and Market Share by Application

6 RUSSIA GENE-DELETED VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Gene-Deleted Vaccines Sales and Value (2011-2016)
  6.1.1 Russia Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
  6.1.2 Russia Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Gene-Deleted Vaccines Sales Price Trend (2011-2016)
6.2 Russia Gene-Deleted Vaccines Sales and Market Share by Manufacturers
6.3 Russia Gene-Deleted Vaccines Sales and Market Share by Type
6.4 Russia Gene-Deleted Vaccines Sales and Market Share by Application

7 ITALY GENE-DELETED VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Gene-Deleted Vaccines Sales and Value (2011-2016)
  7.1.1 Italy Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
  7.1.2 Italy Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Gene-Deleted Vaccines Sales Price Trend (2011-2016)
7.2 Italy Gene-Deleted Vaccines Sales and Market Share by Manufacturers
7.3 Italy Gene-Deleted Vaccines Sales and Market Share by Type
7.4 Italy Gene-Deleted Vaccines Sales and Market Share by Application

8 SPAIN GENE-DELETED VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Gene-Deleted Vaccines Sales and Value (2011-2016)
  8.1.1 Spain Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
  8.1.2 Spain Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Gene-Deleted Vaccines Sales Price Trend (2011-2016)
8.2 Spain Gene-Deleted Vaccines Sales and Market Share by Manufacturers
8.3 Spain Gene-Deleted Vaccines Sales and Market Share by Type
8.4 Spain Gene-Deleted Vaccines Sales and Market Share by Application

9 BENELUX GENE-DELETED VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Gene-Deleted Vaccines Sales and Value (2011-2016)
  9.1.1 Benelux Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Gene-Deleted Vaccines Sales Price Trend (2011-2016)
9.2 Benelux Gene-Deleted Vaccines Sales and Market Share by Manufacturers
9.3 Benelux Gene-Deleted Vaccines Sales and Market Share by Type
9.4 Benelux Gene-Deleted Vaccines Sales and Market Share by Application

10 EUROPE GENE-DELETED VACCINES MANUFACTURERS ANALYSIS

10.1 Bayer HealthCare AG (Germany)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Biogenesis-Bago (Argentina)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Boehringer Ingelheim GmbH (Germany)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Ceva Sante Animale (France)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Ceva Sante Animale (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Heska Corporation (US)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Heska Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Indian Immunologicals Ltd (India)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Lohmann Animal Health (US)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Lohmann Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Merck Animal Health (US)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Merck Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Merial Ltd. (US)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Merial Ltd. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Protein Sciences Corporation (US)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Gene-Deleted Vaccines Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Virbac SA (France)
10.12 Zoetis Inc. (US)

11 GENE-DELETED VACCINES MANUFACTURING COST ANALYSIS

11.1 Gene-Deleted Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Gene-Deleted Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Gene-Deleted Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Gene-Deleted Vaccines Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE GENE-DELETED VACCINES MARKET FORECAST (2016-2021)

14.1 Germany Gene-Deleted Vaccines Sales Forecast (2016-2021)
14.2 France Gene-Deleted Vaccines Sales Forecast (2016-2021)
14.3 UK Gene-Deleted Vaccines Sales Forecast (2016-2021)
14.4 Russia Gene-Deleted Vaccines Sales Forecast (2016-2021)
14.5 Italy Gene-Deleted Vaccines Sales Forecast (2016-2021)
14.6 Spain Gene-Deleted Vaccines Sales Forecast (2016-2021)
14.7 Benelux Gene-Deleted Vaccines Sales Forecast (2016-2021)
14.8 Europe Gene-Deleted Vaccines Sales Forecast by Type (2016-2021)
14.9 Europe Gene-Deleted Vaccines Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Gene-Deleted Vaccines
Table Classification of Gene-Deleted Vaccines
Figure Europe Sales Market Share of Gene-Deleted Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Gene-Deleted Vaccines
Figure Europe Sales Market Share of Gene-Deleted Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure France Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure UK Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Benelux Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Gene-Deleted Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Gene-Deleted Vaccines Revenue and Growth Rate (2011-2021)
Table Europe Gene-Deleted Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Gene-Deleted Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gene-Deleted Vaccines Sales Share by Manufacturers
Figure 2016 Gene-Deleted Vaccines Sales Share by Manufacturers
Table Europe Gene-Deleted Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Gene-Deleted Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Gene-Deleted Vaccines Revenue Share by Manufacturers
Table 2016 Europe Gene-Deleted Vaccines Revenue Share by Manufacturers
Table Europe Gene-Deleted Vaccines Sales and Market Share by Type (2011-2016)
Table Europe Gene-Deleted Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Gene-Deleted Vaccines by Type (2011-2016)
Figure Europe Gene-Deleted Vaccines Sales Growth Rate by Type (2011-2016)
Table Europe Gene-Deleted Vaccines Revenue and Market Share by Type (2011-2016)
Table Europe Gene-Deleted Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gene-Deleted Vaccines by Type (2011-2016)
Figure Europe Gene-Deleted Vaccines Revenue Growth Rate by Type (2011-2016)
Table Europe Gene-Deleted Vaccines Sales and Market Share by Countries (2011-2016)
Table Europe Gene-Deleted Vaccines Sales Share by Countries (2011-2016)
Figure Sales Market Share of Gene-Deleted Vaccines by Countries (2011-2016)
Table Europe Gene-Deleted Vaccines Revenue and Market Share by Countries (2011-2016)
Table Europe Gene-Deleted Vaccines Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Gene-Deleted Vaccines by Countries (2011-2016)
Table Europe Gene-Deleted Vaccines Sales and Market Share by Application (2011-2016)
Table Europe Gene-Deleted Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Gene-Deleted Vaccines by Application (2011-2016)
Figure Germany Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure Germany Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure Germany Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table Germany Gene-Deleted Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Gene-Deleted Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Gene-Deleted Vaccines Sales by Type (2015 and 2016)
Table Germany Gene-Deleted Vaccines Market Share by Type (2015 and 2016)
Table Germany Gene-Deleted Vaccines Sales by Application (2015 and 2016)
Table Germany Gene-Deleted Vaccines Market Share by Application (2015 and 2016)
Figure France Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure France Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure France Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table France Gene-Deleted Vaccines Sales by Manufacturers (2015 and 2016)
Table France Gene-Deleted Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Gene-Deleted Vaccines Sales by Type (2015 and 2016)
Table France Gene-Deleted Vaccines Market Share by Type (2015 and 2016)
Table France Gene-Deleted Vaccines Sales by Application (2015 and 2016)
Table France Gene-Deleted Vaccines Market Share by Application (2015 and 2016)
Figure UK Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure UK Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure UK Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table UK Gene-Deleted Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Gene-Deleted Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Gene-Deleted Vaccines Sales by Type (2015 and 2016)
Table UK Gene-Deleted Vaccines Market Share by Type (2015 and 2016)
Table UK Gene-Deleted Vaccines Sales by Application (2015 and 2016)
Table UK Gene-Deleted Vaccines Market Share by Application (2015 and 2016)
Figure Russia Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure Russia Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure Russia Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table Russia Gene-Deleted Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Gene-Deleted Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Gene-Deleted Vaccines Sales by Type (2015 and 2016)
Table Russia Gene-Deleted Vaccines Market Share by Type (2015 and 2016)
Table Russia Gene-Deleted Vaccines Sales by Application (2015 and 2016)
Table Russia Gene-Deleted Vaccines Market Share by Application (2015 and 2016)
Figure Italy Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure Italy Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure Italy Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table Italy Gene-Deleted Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Gene-Deleted Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Gene-Deleted Vaccines Sales by Type (2015 and 2016)
Table Italy Gene-Deleted Vaccines Market Share by Type (2015 and 2016)
Table Italy Gene-Deleted Vaccines Sales by Application (2015 and 2016)
Table Italy Gene-Deleted Vaccines Market Share by Application (2015 and 2016)
Figure Spain Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure Spain Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure Spain Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table Spain Gene-Deleted Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Gene-Deleted Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Gene-Deleted Vaccines Sales by Type (2015 and 2016)
Table Spain Gene-Deleted Vaccines Market Share by Type (2015 and 2016)
Table Spain Gene-Deleted Vaccines Sales by Application (2015 and 2016)
Table Spain Gene-Deleted Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Gene-Deleted Vaccines Sales and Growth Rate (2011-2016)
Figure Benelux Gene-Deleted Vaccines Revenue and Growth Rate (2011-2016)
Figure Benelux Gene-Deleted Vaccines Sales Price Trend (2011-2016)
Table Benelux Gene-Deleted Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Gene-Deleted Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Gene-Deleted Vaccines Sales by Type (2015 and 2016)
Table Benelux Gene-Deleted Vaccines Market Share by Type (2015 and 2016)
Table Benelux Gene-Deleted Vaccines Sales by Application (2015 and 2016)
Table Benelux Gene-Deleted Vaccines Market Share by Application (2015 and 2016)
Table Gene-Deleted Vaccines Basic Information List
Table Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Gene-Deleted Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Gene-Deleted Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene-Deleted Vaccines
Figure Manufacturing Process Analysis of Gene-Deleted Vaccines
Figure Gene-Deleted Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Gene-Deleted Vaccines Major Manufacturers in 2015
Table Major Buyers of Gene-Deleted Vaccines
Table Distributors/Traders List
Figure Germany Gene-Deleted Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Germany Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure France Gene-Deleted Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure France Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure UK Gene-Deleted Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure UK Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Gene-Deleted Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Russia Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Gene-Deleted Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Italy Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Gene-Deleted Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Spain Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Gene-Deleted Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Gene-Deleted Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Europe Gene-Deleted Vaccines Sales Forecast by Type (2016-2021)
Table Europe Gene-Deleted Vaccines Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories